Department of Ophthalmology and Visual Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Tissue Eng Part C Methods. 2013 Oct;19(10):755-64. doi: 10.1089/ten.TEC.2012.0524. Epub 2013 Mar 15.
We proposed to optimize the retinal differentiation protocols for human embryonic stem cells (hESCs) by improving cell handling. To improve efficiency, we first focused on the production of just one retinal precursor cell type (photoreceptor precursor cells [PPCs]) rather than the production of a range of retinal cells. Combining information from a number of previous studies, in particular the use of a feeder-free culture medium and taurine plus triiodothyronine supplements, we then assessed the values of using size-controlled embryoid bodies (EBs) and negative cell selection (to remove residual embryonic antigen-4-positive hESCs). Using size-controlled 1000 cell EBs, significant improvements were made, in that 78% CRX+ve PPCs could be produced in just 17 days. This could be increased to 93% PPCs through the added step of negative cell selection. Improved efficiency of PPC production will help in efforts to undertake shorter and larger preclinical studies as a prelude to future clinical trials.
我们提出通过改进细胞处理来优化人胚胎干细胞(hESC)的视网膜分化方案。为了提高效率,我们首先专注于产生一种视网膜前体细胞类型(光感受器前体细胞[PPCs]),而不是产生一系列视网膜细胞。结合多项先前研究的信息,特别是使用无饲养层培养介质和牛磺酸加三碘甲状腺素补充剂,我们随后评估了使用大小可控的类胚体(EBs)和阴性细胞选择(去除残留的胚胎抗原-4 阳性 hESC)的价值。使用大小可控的 1000 个细胞的 EB,可使 78%的 CRX+ve PPCs 在短短 17 天内产生,通过添加阴性细胞选择步骤,可将其提高到 93%的 PPCs。提高 PPC 产量的效率将有助于进行更短和更大规模的临床前研究,为未来的临床试验做准备。